INTERPACE BIOSCIENCES, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
INTERPACE BIOSCIENCES, INC. (IDXGD) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $977.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2026-03-30
- 2025-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $977.00K.
- 2025-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $1.77M.
- 2025-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $2.77M.
- 2024-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $4.29M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2025-09-30 | $977.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.77M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $2.77M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $4.29M 10-K · filed 2026-03-30 |
| 2024-09-30 | $5.69M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $6.81M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $9.09M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $9.80M 10-K · filed 2025-03-31 |
| 2023-09-30 | $12.18M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $12.08M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $12.06M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $12.25M 10-K · filed 2024-04-01 |
| 2022-09-30 | $11.13M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $11.07M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $9.68M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $9.88M 10-K · filed 2023-03-27 |
| 2021-09-30 | $2.29M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $2.40M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $2.24M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $2.24M 10-K · filed 2022-03-31 |
| 2020-09-30 | $2.83M 10-Q · filed 2021-01-20 |
| 2020-06-30 | $2.89M 10-Q/A · filed 2021-01-19 |
| 2020-03-31 | $2.92M 10-Q/A · filed 2021-01-19 |
| 2019-12-31 | $2.98M 10-K · filed 2021-04-01 |
| 2019-09-30 | $3.35M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $3.40M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $3.49M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $3.49M 10-K/A · filed 2021-01-19 |
| 2018-09-30 | $2.33M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $1.83M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.91M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $2.05M 10-K · filed 2019-03-21 |
| 2017-09-30 | $2.14M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $3.09M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $1.61M 10-Q · filed 2017-05-12 |
| 2016-12-31 | $7.51M 10-K · filed 2018-03-23 |